Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM
Applied Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 50.76M | 79.4M | 98.87M | 122.2M | 146.48M | 49.9M | 37.46M | 35.62M | 22.92M | 16.66M | 40.39M | 55.73M | 38.21M | 53.89M | 70.21M | 78.43M | 84.07M |
Short-Term Investments | n/a | n/a | n/a | n/a | 253K | n/a | n/a | n/a | n/a | 13.92M | 6.99M | 11.99M | 17.44M | 26.93M | 38.59M | 47.18M | 63.99M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.93M | n/a | n/a | n/a |
Other Long-Term Assets | 253K | 253K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.93M | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | 262K | 262K | 285K | 285K | 285K | 285K | 275K | 276K | 288K | 492K | 525K | 327K | 335K | 591K |
Inventory | n/a | n/a | n/a | n/a | n/a | 3.28M | 4.95M | 6.38M | n/a | 5.32M | -276K | n/a | n/a | -525K | 7.34M | 8.8M | 5.54M |
Other Current Assets | 3.2M | 461K | 619K | 851K | 790K | 666K | 1.79M | 1.88M | 920K | 1.8M | 2.52M | 3.3M | 977K | 2.09M | 3.21M | 4.35M | 686K |
Total Current Assets | 53.97M | 83.65M | 104.6M | 127.57M | 150.91M | 54.39M | 44.49M | 42.82M | 29.06M | 37.31M | 55.51M | 76.9M | 63.56M | 88.39M | 116.94M | 135.25M | 154.41M |
Property-Plant & Equipment | 2.69M | 2.79M | 1.96M | 206K | 328K | 447K | 707K | 825K | 941K | 1.05M | 1.17M | 1.28M | 1.39M | 1.5M | 1.6M | 1.71M | 1.81M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.94M | 3.04M | 1.96M | 206K | 328K | 447K | 707K | 825K | 941K | 1.05M | 1.17M | 1.28M | 1.39M | 1.5M | 1.6M | 1.71M | 1.81M |
Total Assets | 56.91M | 86.69M | 106.57M | 127.78M | 151.23M | 54.83M | 45.2M | 43.65M | 30M | 38.36M | 56.68M | 78.18M | 64.95M | 89.89M | 118.55M | 136.96M | 156.22M |
Account Payables | 4.87M | 4.43M | 2.84M | 2.68M | 4.02M | 1.74M | 6M | 4.69M | 5.55M | 4.53M | 6.97M | 8.69M | 5.92M | 9.46M | 9.17M | 3.31M | 3.48M |
Deferred Revenue | n/a | 212K | n/a | 333K | 477K | 667K | 11.07M | 14.32M | n/a | n/a | n/a | n/a | n/a | 14.78M | 18.61M | 15.94M | 15.36M |
Short-Term Debt | 426K | 406K | n/a | 185K | n/a | 310K | 775K | 1.24M | n/a | 622K | 1.55M | 462K | 453K | n/a | 1.97M | 3.16M | 415K |
Other Current Liabilities | 12.67M | 10.93M | 84.95M | 50.55M | 78.54M | 56.17M | 38.36M | 27.35M | 14.31M | 25.49M | 26.68M | 41.05M | 14.68M | 13.78M | 2.51M | 1.85M | 807K |
Total Current Liabilities | 17.96M | 27.3M | 98.97M | 55.36M | 83.91M | 71.18M | 55.5M | 47.19M | 33.25M | 33.42M | 46.51M | 51.72M | 22.22M | 26.46M | 30.84M | 23.41M | 19.77M |
Long-Term Debt | 2.27M | 2.39M | n/a | 30K | n/a | 38K | 44K | 170K | 534K | 464K | 536K | 655K | 773K | n/a | n/a | 1.11M | 1.22M |
Other Long-Term Liabilities | n/a | n/a | n/a | -30K | n/a | 721K | 647K | 452K | n/a | n/a | -536K | -655K | -773K | n/a | n/a | -1.11M | -1.22M |
Total Long-Term Liabilities | 2.27M | 2.39M | 1.71M | 30K | 35K | 797K | 735K | 792K | 825K | 878K | 536K | 655K | 773K | 891K | 1M | 1.11M | 1.22M |
Total Liabilities | 20.24M | 29.68M | 100.67M | 55.39M | 83.94M | 71.98M | 56.24M | 47.98M | 34.08M | 34.3M | 47.05M | 52.37M | 22.99M | 27.35M | 31.85M | 24.52M | 21M |
Total Debt | 2.7M | 2.79M | 1.97M | 215K | 343K | 777K | 1.31M | 1.9M | 1.31M | 1.98M | 2.56M | 1.12M | 1.23M | 2.12M | 3.41M | 4.7M | 1.64M |
Common Stock | 35K | 35K | 11K | 11K | 11K | 8K | 7K | 6K | 5K | 5K | 5K | 5K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -596.03M | -574.21M | -618.22M | -549.63M | -552.52M | -468.59M | -430.91M | -388.54M | -358.96M | -348.82M | -334.39M | -315.29M | -289.44M | -266.31M | -239.16M | -210.74M | -184.91M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51K | 23K | 6K | -80K | -107K | -254K | -185K | -154K |
Shareholders Equity | 36.67M | 57.01M | 5.89M | 72.39M | 67.29M | -17.15M | -11.04M | -4.33M | -4.07M | 4.06M | 9.63M | 25.81M | 41.96M | 62.54M | 86.7M | 112.44M | 135.22M |
Total Investments | n/a | n/a | n/a | n/a | 253K | n/a | n/a | n/a | n/a | 13.92M | 6.99M | 11.99M | 17.44M | 26.93M | 38.59M | 47.18M | 63.99M |